
Helena Kosanovic
Examiner (ID: 5543, Phone: (571)272-9059 , Office: P/3749 )
| Most Active Art Unit | 3749 |
| Art Unit(s) | 3761, 3762, 3743, 3749 |
| Total Applications | 891 |
| Issued Applications | 401 |
| Pending Applications | 37 |
| Abandoned Applications | 466 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9657450
[patent_doc_number] => 20140228455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-14
[patent_title] => 'DETERMINATION OF BACTERIAL INFECTIONS OF THE GENUS RICKETTSIA AND POSSIBLY BORRELIA, IN PATIENTS EXHIBITING SYMPTOMS OF DISEASE AND BEING BLOOD DONORS'
[patent_app_type] => utility
[patent_app_number] => 14/343567
[patent_app_country] => US
[patent_app_date] => 2012-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7814
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14343567
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/343567 | DETERMINATION OF BACTERIAL INFECTIONS OF THE GENUS RICKETTSIA AND POSSIBLY BORRELIA, IN PATIENTS EXHIBITING SYMPTOMS OF DISEASE AND BEING BLOOD DONORS | Sep 5, 2012 | Abandoned |
Array
(
[id] => 12565929
[patent_doc_number] => 10017550
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-10
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 14/342057
[patent_app_country] => US
[patent_app_date] => 2012-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 22
[patent_no_of_words] => 14836
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14342057
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/342057 | None | Aug 29, 2012 | Issued |
Array
(
[id] => 11276053
[patent_doc_number] => 09492524
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-15
[patent_title] => 'Plague vaccine'
[patent_app_type] => utility
[patent_app_number] => 14/419925
[patent_app_country] => US
[patent_app_date] => 2012-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 10950
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14419925
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/419925 | Plague vaccine | Aug 6, 2012 | Issued |
Array
(
[id] => 8683945
[patent_doc_number] => 20130052229
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-28
[patent_title] => 'COMPOUNDS AND METHODS FOR DIAGNOSIS AND IMMUNOTHERAPY OF TUBERCULOSIS'
[patent_app_type] => utility
[patent_app_number] => 13/560514
[patent_app_country] => US
[patent_app_date] => 2012-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 32515
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13560514
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/560514 | COMPOUNDS AND METHODS FOR DIAGNOSIS AND IMMUNOTHERAPY OF TUBERCULOSIS | Jul 26, 2012 | Abandoned |
Array
(
[id] => 11641165
[patent_doc_number] => 09662515
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-30
[patent_title] => 'Method for producing 4-aminobutyric acid from algae'
[patent_app_type] => utility
[patent_app_number] => 14/239398
[patent_app_country] => US
[patent_app_date] => 2012-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 10542
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14239398
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/239398 | Method for producing 4-aminobutyric acid from algae | Jul 19, 2012 | Issued |
Array
(
[id] => 9970739
[patent_doc_number] => 09017743
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-28
[patent_title] => 'Bacterial extract for digestive or urinary tract disorders and process for its preparation'
[patent_app_type] => utility
[patent_app_number] => 13/528520
[patent_app_country] => US
[patent_app_date] => 2012-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 11
[patent_no_of_words] => 18007
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13528520
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/528520 | Bacterial extract for digestive or urinary tract disorders and process for its preparation | Jun 19, 2012 | Issued |
Array
(
[id] => 9244831
[patent_doc_number] => 08609110
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-17
[patent_title] => 'Citrobacter freundii antibacterial agents and their use'
[patent_app_type] => utility
[patent_app_number] => 13/528633
[patent_app_country] => US
[patent_app_date] => 2012-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 15
[patent_no_of_words] => 23772
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13528633
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/528633 | Citrobacter freundii antibacterial agents and their use | Jun 19, 2012 | Issued |
Array
(
[id] => 9581672
[patent_doc_number] => 08771673
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-08
[patent_title] => 'Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions'
[patent_app_type] => utility
[patent_app_number] => 13/489111
[patent_app_country] => US
[patent_app_date] => 2012-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9776
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13489111
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/489111 | Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions | Jun 4, 2012 | Issued |
Array
(
[id] => 8476725
[patent_doc_number] => 20120276132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-01
[patent_title] => 'Atoxic recombinant holotoxins of Clostridium difficile as immunogens'
[patent_app_type] => utility
[patent_app_number] => 13/486550
[patent_app_country] => US
[patent_app_date] => 2012-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 29167
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13486550
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/486550 | Atoxic recombinant holotoxins of Clostridium difficile as immunogens | May 31, 2012 | Abandoned |
Array
(
[id] => 8370182
[patent_doc_number] => 20120219571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-30
[patent_title] => 'COMBINATION MOTIF IMMUNE STIMULATORY OLIGONUCLEOTIDES WITH IMPROVED ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 13/470729
[patent_app_country] => US
[patent_app_date] => 2012-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 18460
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13470729
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/470729 | COMBINATION MOTIF IMMUNE STIMULATORY OLIGONUCLEOTIDES WITH IMPROVED ACTIVITY | May 13, 2012 | Abandoned |
Array
(
[id] => 9517795
[patent_doc_number] => 20140154287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-05
[patent_title] => 'MULTIPLE ANTIGEN PRESENTING IMMUNOGENIC COMPOSITION, AND METHODS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/116402
[patent_app_country] => US
[patent_app_date] => 2012-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 30854
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14116402
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/116402 | Multiple antigen presenting immunogenic composition, and methods and uses thereof | May 10, 2012 | Issued |
Array
(
[id] => 9174976
[patent_doc_number] => 20130316960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-28
[patent_title] => 'Novel Peptides For Treating and Preventing Immune-Related Disorders, Including Treating And Preventing Infection by Modulating Innate Immunity'
[patent_app_type] => utility
[patent_app_number] => 13/457162
[patent_app_country] => US
[patent_app_date] => 2012-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 21589
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13457162
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/457162 | Peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity | Apr 25, 2012 | Issued |
Array
(
[id] => 8441511
[patent_doc_number] => 20120258128
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-11
[patent_title] => 'Infection Factor Assay'
[patent_app_type] => utility
[patent_app_number] => 13/438453
[patent_app_country] => US
[patent_app_date] => 2012-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13312
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13438453
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/438453 | Infection Factor Assay | Apr 2, 2012 | Abandoned |
Array
(
[id] => 8429702
[patent_doc_number] => 20120251578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-04
[patent_title] => 'Diagnostic, Therapeutic And A Vaccine Against Treponemes'
[patent_app_type] => utility
[patent_app_number] => 13/433258
[patent_app_country] => US
[patent_app_date] => 2012-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6225
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13433258
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/433258 | Diagnostic, therapeutic and a vaccine against treponemes | Mar 27, 2012 | Issued |
Array
(
[id] => 8476739
[patent_doc_number] => 20120276145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-01
[patent_title] => 'EXTRACELLULAR MATRIX PROTEINS FROM HAEMOPHILUS INFLUENZAE BIOFILMS: TARGETS FOR THERAPEUTIC OR DIAGNOSTIC USE'
[patent_app_type] => utility
[patent_app_number] => 13/431592
[patent_app_country] => US
[patent_app_date] => 2012-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 19977
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13431592
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/431592 | EXTRACELLULAR MATRIX PROTEINS FROM HAEMOPHILUS INFLUENZAE BIOFILMS: TARGETS FOR THERAPEUTIC OR DIAGNOSTIC USE | Mar 26, 2012 | Abandoned |
Array
(
[id] => 8290341
[patent_doc_number] => 20120178667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-12
[patent_title] => 'METHODS FOR TREATING SEPTIC SHOCK'
[patent_app_type] => utility
[patent_app_number] => 13/424236
[patent_app_country] => US
[patent_app_date] => 2012-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12843
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13424236
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/424236 | METHODS FOR TREATING SEPTIC SHOCK | Mar 18, 2012 | Abandoned |
Array
(
[id] => 8277369
[patent_doc_number] => 20120171241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-05
[patent_title] => 'ANALYSIS OF SACCHARIDE VACCINES WITHOUT INTERFERENCE'
[patent_app_type] => utility
[patent_app_number] => 13/418211
[patent_app_country] => US
[patent_app_date] => 2012-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8308
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13418211
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/418211 | ANALYSIS OF SACCHARIDE VACCINES WITHOUT INTERFERENCE | Mar 11, 2012 | Abandoned |
Array
(
[id] => 10149037
[patent_doc_number] => 09181313
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-10
[patent_title] => 'Treatment and prevention of malaria'
[patent_app_type] => utility
[patent_app_number] => 13/823979
[patent_app_country] => US
[patent_app_date] => 2012-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 15
[patent_no_of_words] => 10227
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13823979
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/823979 | Treatment and prevention of malaria | Feb 23, 2012 | Issued |
Array
(
[id] => 9944002
[patent_doc_number] => 08993303
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-31
[patent_title] => 'Genetically engineered cyanobacteria'
[patent_app_type] => utility
[patent_app_number] => 13/405208
[patent_app_country] => US
[patent_app_date] => 2012-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 11310
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13405208
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/405208 | Genetically engineered cyanobacteria | Feb 23, 2012 | Issued |
Array
(
[id] => 12526932
[patent_doc_number] => 10005820
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-26
[patent_title] => Therapeutic compositions and methods for antibody and Fc-containing targeting molecule-based targeted delivery of bioactive molecules by bacterial minicells
[patent_app_type] => utility
[patent_app_number] => 13/397313
[patent_app_country] => US
[patent_app_date] => 2012-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 36528
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13397313
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/397313 | Therapeutic compositions and methods for antibody and Fc-containing targeting molecule-based targeted delivery of bioactive molecules by bacterial minicells | Feb 14, 2012 | Issued |